Clinical Trials Tracker

The following clinical trials represent a selection of key studies currently recruiting patients with breast cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with head and neck cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with melanoma for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with esophageal cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with renal-cell carcinoma for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with colo­rectal cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with multiple myeloma for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with leukemia for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with urothelial cancer for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

The following clinical trials represent a selection of key studies currently recruiting patients with gynecologic cancers for inclusion in investigations of new therapies and new regimens of existing treatments for the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. This information can help oncology practice managers and providers direct eligible patients to one of these clinical trials. Read More ›

Page 1 of 6

Subscribe Today!

To sign up for our free e-Newsletter or print publications, please enter your contact information below.

I'd like to receive:

OPM e-Newsletter
OPM print publication